Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1- or IDH2-mutant newly diagnosed acute myeloid leukemia-A multicenter cohort study.
Bewersdorf JP, Shimony S, Shallis RM, Liu Y, Berton G, Schaefer EJ, Zeidan AM, Goldberg A, Stein E, Marcucci G, Bystrom RP, Lindsley RC, Chen EC, Ramos J, Stein A, Pullarkat V, Aldoss I, DeAngelo DJ, Neuberg DS, Stone RM, Garciaz S, Ball B, Stahl M. Bewersdorf JP, et al. Am J Hematol. 2024 Aug;99(8):1640-1643. doi: 10.1002/ajh.27366. Epub 2024 May 15. Am J Hematol. 2024. PMID: 38751104 No abstract available.
Getting personal with myelodysplastic syndromes: is now the right time?
Chokr N, Pine AB, Bewersdorf JP, Shallis RM, Stahl M, Zeidan AM. Chokr N, et al. Among authors: bewersdorf jp. Expert Rev Hematol. 2019 Apr;12(4):215-224. doi: 10.1080/17474086.2019.1592673. Epub 2019 Apr 12. Expert Rev Hematol. 2019. PMID: 30977414 Free PMC article. Review.
Healthcare expenses for treatment of acute myeloid leukemia.
Bewersdorf JP, Shallis RM, Wang R, Huntington SF, Perreault S, Ma X, Zeidan AM. Bewersdorf JP, et al. Expert Rev Hematol. 2019 Aug;12(8):641-650. doi: 10.1080/17474086.2019.1627869. Epub 2019 Jun 13. Expert Rev Hematol. 2019. PMID: 31159602 Review.
One plus one does not always equal two, especially with regard to hypomethylating agents: the question of synergy of azacitidine and lenalidomide for treatment of relapsed acute myeloid leukemia and myelodysplastic syndromes post allogeneic hematopoietic stem cell transplant.
Bewersdorf JP, Stahl M, Zeidan AM. Bewersdorf JP, et al. Expert Rev Hematol. 2019 Aug;12(8):575-578. doi: 10.1080/17474086.2019.1635005. Epub 2019 Jun 26. Expert Rev Hematol. 2019. PMID: 31225770
134 results